Evidence map›Paper›PMID 29171912›Full record

ArticleClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology2018

Concomitant sensitization to legumin, Fag e 2 and Fag e 5 predicts buckwheat allergy.

S Geiselhart, C Nagl, P Dubiela, A C Pedersen, M Bublin, C Radauer, C Bindslev-Jensen, K Hoffmann-Sommergruber, C G Mortz

Abstract read
In one paragraph

Article in Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Buckwheat Allergy in Asia.Current allergy and asthma reports · 2024
    Review
  4. Article
  5. Article
  6. Review
  7. Allergens of Regional Importance in Korea.Frontiers in allergy · 2021
    Review
  8. Article
  9. A WAO - ARIA - GAThe World Allergy Organization journal · 2020
    Article
  10. Concomitant sensitization to legumin, Fag e 2 and Fag e 5 predicts buckwheat allergy.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

S GeiselhartDepartment of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria.ORCID 0000-0002-4749-3485
C NaglDepartment of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria.
P DubielaDepartment of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria.
A C PedersenDepartment of Dermatology and Allergy Center, Odense Research Center for Anaphylaxis (ORCA), Odense University Hospital, Odense, Denmark.
M BublinDepartment of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria.
C RadauerDepartment of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria.ORCID 0000-0001-9920-4449
C Bindslev-JensenDepartment of Dermatology and Allergy Center, Odense Research Center for Anaphylaxis (ORCA), Odense University Hospital, Odense, Denmark.
K Hoffmann-SommergruberDepartment of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria.ORCID 0000-0002-8830-058X
C G MortzDepartment of Dermatology and Allergy Center, Odense Research Center for Anaphylaxis (ORCA), Odense University Hospital, Odense, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBuckwheat (Fagopyrum esculentum) has become increasingly popular as a healthy food in Europe. However, for sensitized individuals, consumption can cause anaphylactic reactions. The aim of this study was to identify individual well-characterized buckwheat allergens for component-resolved diagnosis.

methodsPatients were selected by positive skin prick test to buckwheat and divided into two groups: (1) sensitized to buckwheat without clinical symptoms and (2) buckwheat allergy. Buckwheat proteins were extracted from raw buckwheat seeds, purified applying a combination of protein precipitation and chromatographic methods, and analyzed by IgE immunoblotting and ELISA.

resultsBuckwheat-allergic patients had a significantly larger median skin prick test weal diameter for buckwheat than the sensitized group and the positive control. Also, IgE immunoblotting clearly showed a distinct pattern in sera from allergic patients when compared to sensitized individuals. Several IgE-reactive proteins were purified from crude buckwheat extract, namely legumin (Fag e 1 plus its large subunit), Fag e 2 (2S albumin), and newly identified Fag e 5 (vicilin-like) as well as hevein-like antimicrobial peptides, designated Fag e 4. All four allergens showed superior diagnostic precision compared to extract-based ImmunoCAP with high sensitivity as well as high specificity.

conclusionsPatients with clinical symptoms clearly show a distinct allergen recognition pattern. We characterized a buckwheat vicilin-like protein as a new relevant marker allergen, designated Fag e 5. Additionally, another new allergen, Fag e 4, potentially important for cross-reactivity to latex was added to the allergen panel of buckwheat. Further, our data show that the full-length legumin comprising both, large and small subunit should be applied for component-resolved diagnosis. Our data indicate that concomitant sensitization to legumin, Fag e 2 and Fag e 5, predicts buckwheat allergy.

Indexed as

AdolescentAdultAgedAllergensAntigens, PlantBiomarkersChildEnzyme-Linked Immunosorbent AssayFagopyrumFemaleHumansImmunoglobulin EMaleMiddle AgedPrognosisWheat HypersensitivityAllergensAntigens, PlantBiomarkersFag e 2 allergen, Fagopyrum esculentumImmunoglobulin Eallergensbuckwheatcomponent-resolved diagnosisfood allergyIgE

Identifiers

PMID29171912
PMCPMC5814722

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.